NCT05919732

Brief Summary

It is well established that preterm inguinal hernias discovered in the NICU pose a significant surgical risk due to the associated co-morbid conditions that accompany these patients. Currently, the standard of care in the United States is general anesthesia. There have been studies that have established that elective outpatient repair of inguinal hernias found in the NICU can be safely performed. Patients that are ready for discharge from the NICU will have inguinal hernia repair prior to leaving. Inguinal hernia repair will also be done on those premature infants that are seen in the Nemours surgical clinic. Spinal anesthesia is currently the most common anesthetic procedure used in the surgical treatment of preterm inguinal hernias after general anesthesia. Caudal catheter technique has been proven to safely provide post-operative care of premature infants. The caudal catheter technique involves placement of a small catheter under ultrasound guidance into the caudal epidural canal to allow re-dosing of local anesthetic during the case and has been shown to be safe and effective management in neonates (Somri M, 2007).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Mar 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 8, 2016

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 8, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 8, 2018

Completed
5.3 years until next milestone

First Submitted

Initial submission to the registry

June 16, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 26, 2023

Completed
9 months until next milestone

Results Posted

Study results publicly available

April 2, 2024

Completed
Last Updated

April 2, 2024

Status Verified

March 1, 2024

Enrollment Period

2 years

First QC Date

June 16, 2023

Results QC Date

December 18, 2023

Last Update Submit

March 4, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Number of Participants With Return to Baseline Respiratory Function.

    Within 24 hours post operative

  • Surgical Completion.

    Within 24 hours

  • Number of Apneic Episodes.

    Cessation of breathing by a premature infant that lasts for more than 20 seconds and/or is accompanied by hypoxia or bradycardia.

    24 hours post operative

  • Number of Bradycardia Events.

    heart rate \<90.

    24 hours post operative

Secondary Outcomes (5)

  • Days to Hospital Discharge From Surgery

    up to 10 days

  • Number of Episodes Requiring Post-operative Narcotics Usage.

    24 hours post operative

  • Operative Time.

    Intraoperative, up to 100 minutes.

  • Participants Requiring Mechanical Ventilation.

    After 24 hours post operative

  • Number of Participants Returning to Full Feeds.

    Within 24 hours post operative

Study Arms (2)

Caudal Infusion

EXPERIMENTAL

Awake continuous caudal infusion.

Drug: Bupivacaine, Dexmedetomidine, Caffeine, Tylenol

General anesthesia

ACTIVE COMPARATOR

General anesthesia and single-dose caudal injection

Drug: Propofol, rocuronium, caffeine, Tylenol, bupivacaine

Interventions

bupivacaine .3% + 1: 200,000 epinephrine (dose 3mg/kg). Dexmedetomidine 0.5mcg/kg, Caffeine 15mg/kg, rectal Tylenol 30mg/kg

Caudal Infusion

propofol 3mg/kg and rocuronium 0.6mg/kg. Caffeine 15mg/kg and rectal Tylenol 30mg/kg. single shot caudal with bupivacaine 0.25% + 1:200,000 epinephrine (total dose 2.5mg/kg)

General anesthesia

Eligibility Criteria

Age23 Weeks - 60 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Preterm infants less than 60 weeks post gestational age born at less than 37 weeks gestational age.
  • Patients in the NICU will meet discharge criteria with or without supplemental oxygen prior to surgical scheduling for inguinal hernia repair.

You may not qualify if:

  • Patient undergoing other invasive procedures (i.e. gastrostomy tube placement, tracheostomy, laser eye treatment)
  • Medical condition that would prevent a regional anesthetic from being performed (i.e. bleeding diathesis, vertebral anomalies, and spinal cord injury prior to surgery)
  • Contradictions to the prescribed medications in the protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nemours Children's Clinic

Jacksonville, Florida, 32207, United States

Location

MeSH Terms

Conditions

Hernia, Inguinal

Interventions

BupivacaineDexmedetomidineCaffeineAcetaminophenPropofolRocuronium

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsXanthinesAlkaloidsPurinonesPurinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingAcetanilidesPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsAndrostanolsAndrostanesSteroidsFused-Ring CompoundsPolycyclic Compounds

Results Point of Contact

Title
Dr. Gohalem Felema
Organization
Nemours

Study Officials

  • Robert B Bryskin, MD

    Nemours Children's Clinic

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
The statistician for the study will generate a randomization table. An unblinded research coordinator will prepare randomization envelopes which will be numbered sequentially and placed in a bin located in the secure medication room in the peri-operative suite.Intra-operatively, neither the anesthesiologist nor the surgeon will be blinded since they are present from the induction of anesthesia until the conclusion of the operation for patient safety. The doctors, nurses and others caring for the infant postoperatively will be blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A prospective, blinded, randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiologist

Study Record Dates

First Submitted

June 16, 2023

First Posted

June 26, 2023

Study Start

March 8, 2016

Primary Completion

March 8, 2018

Study Completion

March 8, 2018

Last Updated

April 2, 2024

Results First Posted

April 2, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will share

Locations